Search Results for "New Treatment For Hepatitis B"

08:07 EDT 28th October 2016 | BioPortfolio

Matching Channels

Hepatitis B

Hepatitis A

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Hepatitis E virus HEV

Hepatitis B virus HBV

Matching News

Introducing Epclusa

The treatment options for hepatitis C infections just gained a member to the club. There are six genotypes (numbered 1-6) of the hepatitis C virus. Previously, hepatitis C medications generally worked...

The Hepatitis C Trust considers legal action over cap on NHS patients allowed to seek treatment

NHS England is limiting treatment with new drugs for hepatitis C to 10,000 of the most in-need patients, prompting The Hepatitis C Trust to consider seeking a judicial review of the decision.

Hepatitis C

Learning Objectives: 1. Understand the six genotypes related to hepatitis C virus (HCV). 2. List the medications and treatment options for the 6 genotypes of HCV. 3. Describe the testing for HCV a...

Longevity After Hepatitis C Treatment

Before direct-acting antiviral medications came on the scene for treating hepatitis C, this disease was often a death sentence for patients who progressed to liver failure or liver cancer. However, ov...

Provisional NICE recommendation for Gilead’s Hepatitis C treatment

NICE has issued provisional guidance recommending the use of Gilead Sciences’ Epclusa (sofosbuvir 400 mg/velpatasvir 100 mg) for the treatment of adult chronic hepatitis C genotype 1-6 patients in E...

Hepatitis C Treatment Delivery Mandates

This Viewpoint describes how a shortage of health care workers providing treatment for hepatitis C hinders access to treatment, despite progress in drug efficacy and reductions in drug costs.

FDA approves a Gilead pill that is first to treat all forms of hepatitis C

The drug maker's new treatment can be used for all six strains of hepatitis C, and at about $75,000 for a 12-week course of treatment, it costs less than two…

The AIDS Institute Recognizes World Hepatitis Day – Hepatitis Can Be Eliminated as a Public Health Threat

The AIDS Institute is proud to support the World Health Organization’s World Hepatitis Day, and its goal of eliminating hepatitis globally. World Hepatitis Day, created in 2010, is one of only four ...

Matching PubMed Articles

Antiviral treatment and liver-related complications in hepatitis delta.

Hepatitis delta is the most severe form of viral hepatitis. Pegylated interferon alfa (PEG- IFNα) is effective in only 25-30% of patients and is associated with frequent side effects. The aim of this...

Update on Hepatitis C treatment: Systematic review of clinical trials.

Chronic Hepatitis C is a major public health problem. The chronicity of the Hepatitis C can lead to advanced liver disease, cirrhosis and even hepatocellular carcinoma. Chronic hepatitis C is the lead...


Occult hepatitis B infection is characterized by negative hepatitis B surface antigen (HBsAg) and also detectable hepatitis B virus (HBV) -DNA, with or without hepatitis B core antibody (anti-HBc). HB...

Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.

Previous studies have shown that hepatitis B core antibody (anti-HBc) levels vary during different phases of disease in treatment-naïve chronic hepatitis B (CHB) patients and can be used as a predict...

Management and treatment of patients with hepatitis B.

Chronic hepatitis B is a major cause of morbidity and mortality worldwide. Approximately one third of the world's population has serological evidence of past or present infection by hepatitis B virus ...

Search Whole site using Google

Quick Search
Advertisement Advertisement